Triple-negative breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal
women and is highly prevalent in African American women. TNBC is a term derived …

Background Despite median survival of less than 6 months, there is a significant proportion
of advanced pancreatic cancer patients who progress on gemcitabine that remains fit, and …

Abstract Evaluation of the feasibility and efficacy of neoadjuvant concurrent chemoradiotherapy
(CRT) with capecitabine and oxaliplatin in patients with locally advanced esophageal …

Background Worldwide, esophageal cancer is the eighth most common cancer and the
sixth leading cause of cancer-related death. At initial diagnosis, about 50% of esophageal …

The objective of this study was to compare concomitant chemoradiotherapy based on weekly
low-dose gemcitabine versus weekly low-dose paclitaxel in locally advanced head and …

Objective To explore if the addition of adjuvant chemotherapy with paclitaxel and carboplatin
to radiotherapy confers an advantage for overall survival (OAS), and progression free …

Objective To evaluate toxicity and efficacy of addition of weekly irinotecan to a regimen of
chemoradiotherapy of 5-fluorouracil with concurrent pelvic radiation in patients with locally …

Objective The objective of this study was to evaluate the results of combined chemoradiotherapy
using 5-fluorouracil and cisplatin with radiation in treatment of anal squamous cell …

Objective several trials have suggested the superiority of concurrent chemoradiotherapy. It
has been hypothesized that the addition of systemic dose sequential chemotherapy to …

Background: Small cell lung cancer (SCLC) is a high grade neuroendocrine tumor, and has
aggressive nature, so the majority of cases are presented with extensive disease. SCLC was …